"As we saw with the recent Ebola outbreak, sometimes people present with symptoms and it's not clear what they have," said Kimberly Hamad-Schifferli, a visiting scientist in Massachusetts Institute of Technology's Department of Mechanical Engineering and a member of the technical staff at MIT's Lincoln Laboratory.
"We wanted to come up with a rapid diagnostic that could differentiate between different diseases," Hamad-Schifferli said.
Currently, the only way to diagnose Ebola is to send patient blood samples to a lab that can perform advanced techniques such as polymerase chain reaction (PCR), which can detect genetic material from the Ebola virus.
The new MIT device relies on lateral flow technology, which is used in pregnancy tests and has recently been exploited for diagnosing strep throat and other bacterial infections.
Also Read
Until now, however, no one has applied a multiplexing approach, using multicoloured nanoparticles, to simultaneously screen for multiple pathogens.
Unlike most existing paper diagnostics, which test for only one disease, the new MIT strips are colour-coded so they can be used to distinguish among several diseases.
The researchers created red, orange, and green nanoparticles and linked them to antibodies that recognise Ebola, dengue fever, and yellow fever.
As a patient's blood serum flows along the strip, any viral proteins that match the antibodies painted on the stripes will get caught, and those nanoparticles will become visible.
This can be seen by the naked eye; for those who are colourblind, a cellphone camera could be used to distinguish the colours.
"When we run a patient sample through the strip, if you see an orange band you know they have yellow fever, if it shows up as a red band you know they have Ebola, and if it shows up green then we know that they have dengue," Hamad-Schifferli said.
The test is described in the journal Lab on a Chip.